The current HPV vaccine recommendations apply to 9 years old and above through the age of 26 years and adults aged 27-45 years who might be at risk of new HPV infection and benefit from vaccination. (mdpi.com)
Human papillomavirus vaccination rates in adolescents with cerebral palsy compared to the general population. (childrensmercy.org)
A Learning Collaborative Model to Improve Human Papillomavirus Vaccination Rates in Primary Care. (childrensmercy.org)
Caregiver and adolescent factors associated with delayed completion of the three-dose human papillomavirus vaccination series. (childrensmercy.org)
Practice Transformation Program to increase adolescent human papillomavirus, meningococcal, tetanus-diphtheria-pertussis and influenza vaccination. (childrensmercy.org)
Adolescent1
Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals. (emmes.com)
Doses2
Numbers of reported AEFIs, reporting rates (reports per 100,000 doses of distributed vaccine or per person-years at risk), and comparisons with expected background rates. (nih.gov)
The originally recommended dosing schedule, 0, 2, 6 months, for the 3-dose quadrivalent human papillomavirus vaccine (4vHPV) was often not followed, resulting in longer than recommended intervals between doses and interest in the effect of prolonged intervals. (emmes.com)
Clinical trials2
Adenocarcinoma in situ and associated human papillomavirus type distribution observed in two clinical trials of a quadrivalent human papillomavirus vaccine por: Ault K.A., et al. (ccb.org.co)
The preventive effect of HPV vaccines against anogenital and oropharyngeal cancers has been proven in both clinical trials and real-world data. (mdpi.com)
Uptake3
Little is known, however, which strategies (if any) used within a school-based program help to improve vaccine uptake. (mcmaster.ca)
METHODS: A retrospective, exploratory correlation study was conducted to examine the relationship between school-based strategies and uptake of HPV vaccine. (mcmaster.ca)
Bradley-Ewing A, Lee BR, Doctor JN, Meredith G, Goggin K, Myers A. A pilot intervention combining assessment and feedback with communication training and behavioral nudges to increase HPV vaccine uptake. (childrensmercy.org)
Cervical5
Human papillomavirus (HPV) infection must be present for cervical cancer to occur. (medscape.com)
BACKGROUND: Nova Scotia has the highest rate of cervical cancer in Canada, and most of these cases are attributed to the Human Papillomavirus (HPV). (mcmaster.ca)
Attribution of 12 high-risk human papillomavirus genotypes to infection and cervical disease por: Joura, Elmar A., et al. (ccb.org.co)
A pooled analysis of continued prophylactic efficacy of quadrivalent human papillomavirus (types 6/11/16/18) vaccine against high-grade cervical and external genital lesions por: Kjaer, Susanne K., et al. (ccb.org.co)
Papillomavirus Vaccines" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings) . (childrensmercy.org)
Most of the AEFI rates were not greater than the background rates compared with other vaccines, but there was disproportional reporting of syncope and venous thromboembolic events. (nih.gov)
Women1
Background The impact of the prophylactic vaccine against human papillomavirus (HPV) types 6, 11, 16, and 18 (HPV6/11/16/18) on all HPV-associated genital disease was investigated in a population that approximates sexually naive women in that they were 'negative to 14 HPV types' and in a m. (ccb.org.co)
4vHPV6
The quadrivalent HPV vaccine (4vHPV) was originally recommended as a three-dose series (0/2/6 months), though delays in completing the series frequently occur. (nih.gov)
The originally recommended dosing schedule, 0, 2, 6 months, for the 3-dose quadrivalent human papillomavirus vaccine (4vHPV) was often not followed, resulting in longer than recommended intervals between doses and interest in the effect of prolonged intervals. (emmes.com)
Prospective controlled studies with participants consisting exclusively of healthy women who received bivalent, quadrivalent, or 9-valent HPV (2vHPV, 4vHPV or 9vHPV) vaccines were included. (biomedcentral.com)
A significantly higher incidence of solicited local symptoms was observed following injection of HPV vaccines (2vHPV and 4vHPV) compared to placebo, but there was no difference between HPV vaccines [risk ratio (RR) for 2vHPV: 1.25, 95% confidence interval (CI): 1.09 to 1.43, RR for 4vHPV: 1.16, 95% CI: 1.11 to 1.20]. (biomedcentral.com)
HPV vaccines had significantly higher risk of any injection site symptom compared to placebo or other vaccines (hepatitis A and B vaccines), and the incidence of solicited local symptoms was no difference between 2vHPV vaccination and 4vHPV vaccination. (biomedcentral.com)
Among three internationally marketed HPV vaccines [bivalent HPV (2vHPV), quadrivalent HPV (4vHPV), and 9-valent HPV (9vHPV) vaccines], 2vHPV and 4vHPV are now being marketed in Japan. (biomedcentral.com)
Bivalent1
Pfizer ABRYSVO RSVpreF PF-06928316 RSV bivalent vaccine based on the prefusion form of the RSV fusion protein. (precisionvaccinations.com)
Antibody3
Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals. (emmes.com)
To assess robustness of mRNA vaccine-induced immunity, we compared antibody durability and breadth after SARS-CoV-2 infection and vaccination. (biorxiv.org)
By illuminating an infection-mediated antibody breadth advantage and an anti-SARS-CoV-2 antibody durability-enhancing function conferred by recalled immunity, these findings may serve as guides for ongoing vaccine strategy improvement. (biorxiv.org)
Hepatitis vaccine1
Of the 24 studies, 16 were placebo-controlled and eight were active-controlled (different HPV vaccine or hepatitis vaccine). (biomedcentral.com)
Elicit2
Understanding the capabilities of the immune system in this regard, and how available vaccines can elicit them is a critical step in this process, both for the ongoing SARS-CoV-2 pandemic as well as for vaccine strategies more broadly. (biorxiv.org)
Adenovirus Type 4 and Type 7 Vaccine elicit immunity to adenovirus serotypes 4 and 7 which are most often associated with acute respiratory disease. (precisionvaccinations.com)
ACIP1
These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a quadrivalent human papillomavirus (HPV) vaccine licensed by the U.S. Food and Drug Administration on June 8, 2006. (cdc.gov)
Adjuvant2
The quadrivalent HPV vaccine is a mixture of four HPV type-specific VLPs prepared from the L1 proteins of HPV 6, 11, 16, and 18 combined with an aluminum adjuvant. (cdc.gov)
AREXVY monovalent RSV vaccine recombinant AS01E adjuvanted contains a recombinant subunit pre-fusion RSV antigen combined with a proprietary AS01 adjuvant. (precisionvaccinations.com)
Adverse2
However, the number of women who receive HPV vaccinations has decreased over the last several years in Japan, due to concerns about adverse reactions associated with the vaccines. (biomedcentral.com)
We evaluated the safety of three types of HPV vaccines separately in young women and the difference in the risk of adverse reactions between HPV and other vaccines by conducting a meta-analysis. (biomedcentral.com)
Vaccination2
This report summarizes the epidemiology of HPV and associated diseases, describes the licensed HPV vaccine, and provides recommendations for its use for vaccination among females aged 9--26 years in the United States. (cdc.gov)
However, females infected with one or more vaccine HPV types before vaccination would be protected against disease caused by the other vaccine HPV types. (cdc.gov)
Females1
Clinical trials indicate that the vaccine has high efficacy in preventing persistent HPV infection, cervical cancer precursor lesions, vaginal and vulvar cancer precursor lesions, and genital warts caused by HPV types 6, 11, 16, or 18 among females who have not already been infected with the respective HPV type. (cdc.gov)
Diseases1
Alzheimer's disease vaccines prevent degenerative brain diseases caused by complex brain changes following cell damage. (precisionvaccinations.com)
Protein4
The licensed HPV vaccine is composed of the HPV L1 protein, the major capsid protein of HPV. (cdc.gov)
AADvac1 is a therapeutic vaccine candidate for Alzheimer's disease that targets misfolded tau protein. (precisionvaccinations.com)
Altimmune Inc.'s AdCOVID COVID-19 vaccine candidate was based on an adenovirus-based intranasal vaccine platform and expresses the receptor-binding domain of the SARS-CoV-2 spike protein. (precisionvaccinations.com)
AG0301 COVID-19 Vaccine candidate is a plasmid DNA vaccine that disables the connection between the protein spikes of the coronavirus and receptors in human cells. (precisionvaccinations.com)
Department of Healt1
Established under the National Cancer Institute Act of 1937, NCI is part of the National Institutes of Health (NIH), one of 11 agencies that make up the Department of Health and Human Services (HHS). (nih.gov)
Young1
Vaccine can be administered as young as age 9 years. (cdc.gov)